Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study

Trial Profile

Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aztreonam (Primary)
  • Indications Cystic fibrosis
  • Focus Proof of concept; Therapeutic Use
  • Acronyms MOMMI1
  • Most Recent Events

    • 07 Sep 2016 Status changed from recruiting to completed.
    • 05 Jan 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
    • 05 Jan 2015 Treatment period has been changed from 56 days to 28 days, patient number decreased from 40 to 22 and date and time of dosing, dose amount by drug removed from treatment table.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top